Matthew Hirsch

President & Co-Founder at Bedrock Therapeutics

Matt left his home state of Pennsylvania to “Wild and Wonderful” West Virginia University where he graduated Phi Beta Kappa and summa cum laude in Biology. Matt elucidated the role of the stress response regulator, RpoS, in E. coli and Salmonella to obtain his PhD under the guidance of the classical geneticist Tom Elliott. Then, Matt trained with Jude Samulski at the University of North Carolina and found it difficult to leave the beautiful weather and AAV community in Chapel Hill. Currently, Matt is an associate professor at UNC in Ophthalmology and has over 50 gene therapy publications related to both AAV biology and preclinical drug development.

Links


Timeline

  • President & Co-Founder

    Current role